Copart (CPRT) Following Mixed Results Has The Market Questioning Its Undervalued Narrative

Copart (CPRT) is back in focus after reporting fourth quarter and full year results to July 31, 2026, with modest revenue gains alongside lower net income and earnings per share.

Recent trading tells a cautious story for Copart. The latest share price of $28.87 comes after the 30 day share price return declined 13.21% and the year to date share price return fell 23.58%, while the 1 year total shareholder return declined 36.41%. This points to fading momentum despite the recent earnings update.

See how Copart's pullback compares with other businesses screened for resilient balance sheets and steady fundamentals by checking the list of solid balance sheet and fundamentals (23 results) in the same space.

For Copart, a softer share price alongside only modest changes in earnings can either signal a real shift in the business or a mood swing in the market. The valuation now has to carry that argument.

Most Popular Narrative: 41% Undervalued

On the narrative view, Copart's current share price of $28.87 sits well below a fair value estimate of $49. That gap frames the stock as a mispriced compounder rather than a broken story.

The market appears to be treating slower growth as evidence that the moat has weakened.

I do not think the evidence supports that yet.

See why 44 investors see Copart as 41% undervalued.

This narrative is grounded in a few specific pillars. It points to a US operation that has stalled, an international segment that remains on the front foot, net margins that still sit above 30%, and a balance sheet that carries conservative funding.

On top of that qualitative view, the Simply Wall St DCF framework currently assigns Copart a future cash flow value of $57.39 per share, which is materially above the latest close. The model projects future cash flows and discounts them back using a 7.108% rate, then compares that output with the traded price to frame the potential gap.

Supporters of this approach argue that a business earning high returns on capital and converting a large share of revenue into free cash flow can justify a fair value that looks rich against near term growth forecasts. Critics point out that Copart's earnings are forecast to grow 6.61% per year and that both revenue and profit expansion are expected to trail the broader US market. This puts more weight on the quality and durability of the existing moat.

According to WealthAP, the core of the debate is not whether Copart is a solid operator but whether that moat can keep compounding at a pace that matches the narrative fair value. That is why the same data can screen as "good value" on P/E comparisons, "undervalued" on a DCF basis, yet still look uninspiring to investors who want faster growth.

Result: Fair Value of $49 (UNDERVALUED)

Still, the Copart story can crack if US operations remain sluggish for years while international expansion fails to absorb the group’s current cost base.

Find out about the key risks to this Copart narrative.

Next Steps

Feeling that the Copart narrative leans optimistic or cautious for your own taste is only useful if you stress test it against the numbers. Move quickly from headline impressions to evidence and check how those positives stack up in the 3 key rewards

Looking for more Copart sized investment ideas?

If you stop with Copart, you miss the wider opportunity set. Put fresh ideas on your radar now while others stay anchored to a single ticker.

• Target value with quality by scanning companies that combine strong fundamentals with room for a re rating through the 30 high quality undervalued stocks.
• Prioritise resilience by reviewing a 31 resilient stocks with low risk scores that filters for sturdier balance sheets and calmer price swings.
• Get ahead of the crowd by checking a 16 high quality undiscovered gems before capital chases the same familiar stories.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com